Related Experiment Video
Updated: May 25, 2026

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.
Roxana Sulica1, Teresa De Marco2, Sonia Bartolome3
1NYU Langone Health, New York University, New York, NY.
Critically ill patients with pulmonary arterial hypertension (PAH) experiencing right ventricular failure (RVF) require intensive care unit (ICU) management focused on optimizing RV function and treating reversible precipitants. Key strategies include hemodynamic support, metabolic correction, and monitoring for complications.
Area of Science:
- Cardiology
- Critical Care Medicine
- Pulmonology
Background:
- Pulmonary hypertension (PH) poses significant challenges in critically ill patients, often leading to right ventricular failure (RVF).
- Acute illness can precipitate decompensated RVF and death in patients with PH, with high mortality rates in intensive care units (ICUs).
- Right ventricular failure is a primary cause of mortality in hospitalized patients with PH.
Purpose of the Study:
- To outline the intensive care unit (ICU) management strategies for acute decompensated right ventricular failure (RVF) in patients with pulmonary arterial hypertension (PAH).
- To emphasize the importance of recognizing and treating reversible precipitants of decompensation.
- To detail supportive measures for optimizing right ventricular (RV) function.
Main Methods:
- Focus on management of acute decompensated RVF in patients with known PAH.
- Implementation of supportive strategies to optimize RV function.
- Continuous monitoring of cardiac function and management of complications like arrhythmias and acute kidney injury (AKI).
Main Results:
- Management centers on treating reversible precipitants and optimizing RV function.
- Key goals include maintaining oxygenation, tissue perfusion, electrolyte balance, and RV preload, contractility, and afterload.
- Extracorporeal life support is considered for persistent RVF.
Conclusions:
- Comprehensive ICU management of PAH patients with RVF requires addressing reversible factors and providing hemodynamic support.
- Continuous monitoring, complication management, and consideration of advanced therapies like extracorporeal life support are crucial.
- Multidisciplinary care, including palliative specialists, is essential for advanced disease and guiding goals of care.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Heart Failure V: Medical Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiomyopathy VI: Nursing Management
